AlanDavidFriedmanMD
Pediatric Hematology & Oncology • Baltimore, MDProfessor of Oncology, Professor of Pediatrics, Johns Hopkins University School of Medicine; Professor, Oncology and Pediatrics
Dr. Friedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Bloomberg 11N
Baltimore, MD 21287Phone+1 410-955-8751Fax+1 410-614-1802
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1986 - 1989
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1983 - 1986
Harvard Medical SchoolClass of 1983
Certifications & Licensure
MD State Medical License 1986 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- Join now to see all
Clinical Trials
- Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
- Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by ...Mohammad A Alzubi, Theresa Barberi, Alan D Friedman
Cancer Immunology, Immunotherapy. 2025-02-04 - Acute lymphoblastic leukemia of the central nervous system presenting with rapid weight gain.Connor P Hall, Alan D Friedman
Pediatric Blood & Cancer. 2023-03-01 - 2 citationsAdoptive transfer of immature myeloid cells lacking NF-κB p50 (p50-IMC) impedes the growth of MHC-matched high-risk neuroblastoma.Cheng Cui, Theresa Barberi, Rahul Suresh, Alan D. Friedman
Molecular Oncology. 2021-07-01
Journal Articles
- Progression from the Common Lymphoid Progenitor to B/Myeloid PreproB and ProB Precursors During B Lymphopoiesis Requires C/EBPαAlan Friedman, MD, The Journal of Immunology
Grant Support
- Regulation Of Monocyte And Granulocyte Lineage SpecificationNational Heart, Lung, And Blood Institute2009–2012
- Basic And Translational Research Of Ipsc-Based Hematologic And Vascular TherapiesNational Heart, Lung, And Blood Institute2009–2011
- Transcriptional And Epigenetic Regulation Of HSC Generated From IPS And ESCNational Heart, Lung, And Blood Institute2009
- Role Of C/Ebpalpha In MDS And MDS ProgressionNational Heart, Lung, And Blood Institute2005–2008
- Cell Cycle Regulation And Leukemogenesis By Cbfb-SmmhcNational Cancer Institute2003–2007
- A Transcriptional Program Regulating MyelopoiesisNational Heart, Lung, And Blood Institute2001–2004
- Transcriptional Control In Hematopoietic Myeloid CellsNational Heart, Lung, And Blood Institute1995–1998
- Mechanisms Of Trans-Activation Of Herpesvirus GenesNational Cancer Institute1988–1992
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/alan-friedman
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
